ISR AMEX
Isoray, Inc.
1W: -4.0%
1M: +36.8%
3M: +1.1%
1Y: +2.0%
3Y: -55.4%
5Y: -14.6%
$0.38
Last traded 2023-02-17 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$0.0M
52W Range0.19-0.45
Volume145,041
Avg Volume257,331
Beta0.00
Dividend—
Analyst Ratings
Company Info
CEOLori A. Holmes-Woods
Employees66
SectorHealthcare
IndustryMedical - Devices
IPO Date2002-05-31
Websiteisoray.com
350 Hills Street
Richland, WA 99354
US
Richland, WA 99354
US
509 375 1202
About Isoray, Inc.
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Williamson Robert F | P-Purchase | 3,663 | $0.33 | 2023-12-21 |
| Williamson Robert F | P-Purchase | 13,680 | $0.32 | 2023-12-19 |
| Puhlmann Markus | P-Purchase | 400,000 | $0.34 | 2023-12-19 |
| Hunt Jonathan Robert | P-Purchase | 125,000 | $0.26 | 2023-12-18 |
| Williamson Robert F | P-Purchase | 10,000 | $0.26 | 2023-12-18 |